Feng Chi Biotech (ROCO:6744) Beta: 0.0594 (As of Jun. 26, 2026)


ROCO:6744 Feng Chi Biotech Corp ROCO:6744
79 GF Score
Price NT$15.20
GF Value NT$20.86
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Feng Chi Biotech Beta?

Feng Chi Biotech ROCO:6744 +2.70% 79 Beta is 0.0594 as of Jun. 26, 2026. GuruFocus rates ROCO:6744 with a GF Score™ of 79/100 and a GF Value™ of NT$20.86 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-26), Feng Chi Biotech's Beta is 0.0594.


Feng Chi Biotech  (ROCO:6744) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Feng Chi Biotech Beta Related Terms


Feng Chi Biotech Beta Historical Data

* Premium members only.

The historical data trend for Feng Chi Biotech's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Feng Chi Biotech Beta Chart

Feng Chi Biotech Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.26 0.00 0.05 0.00

Feng Chi Biotech Semi-Annual Data
Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.05 0.05 0.00 0.00

ROCO:6744 vs VRTX, REGN, ALNY: Beta Comparison

For the Biotechnology subindustry, Feng Chi Biotech's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Feng Chi Biotech Beta vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Feng Chi Biotech's Beta distribution charts can be found below:

* The bar in red indicates where Feng Chi Biotech's Beta falls into.


ROCO:6744
79GF Score
Feng Chi Biotech Corp ROCO:6744
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Feng Chi Biotech Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 0.0594 mean?
Feng Chi Biotech (ROCO:6744) has a Beta of 0.0594 as of Jun. 26, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Feng Chi Biotech and its competitors.
Is Feng Chi Biotech's Beta too high?
Feng Chi Biotech's current Beta is 0.0594. Overall, Feng Chi Biotech has a GF Score™ of 79/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Feng Chi Biotech's Beta compare to VRTX and REGN?
Feng Chi Biotech's Beta of 0.0594 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Biotechnology company?
A good Beta depends on the Biotechnology industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Feng Chi Biotech and its competitors. Feng Chi Biotech's current Beta is 0.0594. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Feng Chi Biotech stock overvalued right now?
Based on GuruFocus' analysis, Feng Chi Biotech (ROCO:6744) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$20.86, compared to a current price of NT$15.20 — trading 27.1% below its estimated fair value. The current Beta is 0.0594. Feng Chi Biotech's overall GF Score™ is 79/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Feng Chi Biotech (ROCO:6744), the current Beta is 0.0594 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Feng Chi Biotech (ROCO:6744) Overvalued in 2026?

Based on GuruFocus' analysis, Feng Chi Biotech stock appears to be undervalued. The current stock price of NT$15.20 is trading 27.1% below its estimated GF Value™ of NT$20.86. GuruFocus considers Feng Chi Biotech to be Modestly Undervalued.

Key valuation signals for ROCO:6744:

  • Beta: 0.0594
  • GF Value™: NT$20.86 vs. price of NT$15.20 (27.1% below fair value)
  • GF Score™: 79/100 with 4 warning signs

No single metric tells the full story. See the ROCO:6744 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Feng Chi Biotech Business Description

Address No. 5, Shaoxing North Street, 5th Floor-1, Zhongzheng District, Taipei City, TWN, 100
Feng Chi Biotech Corp provide promotion and support for clinical testing and molecular genetic medicine research related technologies. The company's products and services include clinical testing, food testing, newborn screening, prenatal screening, iron stomach, interscience, and colony counting.
79GF Score

Get the complete analysis for ROCO:6744

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$15.20
Price
NT$20.86
GF Value